Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Adolfsson

Showing results (61-70 of 168) with videos related to

Pageof 17
Sort By:
Scandinavian Journal of Public Health|April 27, 2017
Waiting times for cancer patients in Sweden: A nationwide population-based studyStephanie Robertson, Jan Adolfsson, Pär Stattin, et al.
Plos One|July 11, 2018
Predictors of participation in risk-based prostate cancer screeningMarie Koitsalu, Martin Eklund, Jan Adolfsson, et al.
Cancer Research|November 17, 2006
Germ-line genetic variation in the key androgen-regulating genes androgen receptor, cytochrome P450, and steroid-5-alpha-reductase type 2 is important for prostate cancer developmentSara Lindström, Fredrik Wiklund, Hans-Olov Adami, et al.
Breast Cancer Research and Treatment|July 26, 2012
Impact of comorbidity on management and mortality in women diagnosed with breast cancerAnders Berglund, Annette Wigertz, Jan Adolfsson, et al.
European Urology|October 23, 2012
Prostate-specific antigen (PSA) testing is prevalent and increasing in Stockholm County, Sweden, Despite no recommendations for PSA screening: results from a population-based study, 2003-2011Tobias Nordström, Markus Aly, Mark S Clements, et al.
European Urology Focus|February 14, 2018
Poor Follow-up After Elevated Prostate-specific Antigen Tests: A Population-based Cohort StudyMarkus Aly, Mark Clements, Caroline E Weibull, et al.
BMC Cancer|November 23, 2021
Exploring the association between use of gonadotropin releasing hormones agonists and prostate cancer diagnosis per se and diabetes control in men with type 2 diabetes mellitus: a nationwide, population-based cohort studyE Lin, Hans Garmo, Mieke Van Hemelrijck, et al.
European Journal of Cancer (Oxford, England : 1990)|January 23, 2013
Risk of suicide in men with low-risk prostate cancerSigrid Carlsson, Fredrik Sandin, Katja Fall, et al.
Breast Cancer Research and Treatment|April 19, 2014
Birth size in the most recent pregnancy and maternal mortality in premenopausal breast cancer by tumor characteristicsMohammadhossein Hajiebrahimi, Sven Cnattingius, Mats Lambe, et al.
BJU International|January 22, 2015
Causes of death in men with localized prostate cancer: a nationwide, population-based studyMieke Van Hemelrijck, Yasin Folkvaljon, Jan Adolfsson, et al.
Pageof 17

Showing results (61-70 of 168) with videos related to

Sort By:
Pageof 17
Scandinavian Journal of Public Health|April 27, 2017
Waiting times for cancer patients in Sweden: A nationwide population-based studyStephanie Robertson, Jan Adolfsson, Pär Stattin, et al.
Plos One|July 11, 2018
Predictors of participation in risk-based prostate cancer screeningMarie Koitsalu, Martin Eklund, Jan Adolfsson, et al.
Cancer Research|November 17, 2006
Germ-line genetic variation in the key androgen-regulating genes androgen receptor, cytochrome P450, and steroid-5-alpha-reductase type 2 is important for prostate cancer developmentSara Lindström, Fredrik Wiklund, Hans-Olov Adami, et al.
Breast Cancer Research and Treatment|July 26, 2012
Impact of comorbidity on management and mortality in women diagnosed with breast cancerAnders Berglund, Annette Wigertz, Jan Adolfsson, et al.
European Urology|October 23, 2012
Prostate-specific antigen (PSA) testing is prevalent and increasing in Stockholm County, Sweden, Despite no recommendations for PSA screening: results from a population-based study, 2003-2011Tobias Nordström, Markus Aly, Mark S Clements, et al.
European Urology Focus|February 14, 2018
Poor Follow-up After Elevated Prostate-specific Antigen Tests: A Population-based Cohort StudyMarkus Aly, Mark Clements, Caroline E Weibull, et al.
BMC Cancer|November 23, 2021
Exploring the association between use of gonadotropin releasing hormones agonists and prostate cancer diagnosis per se and diabetes control in men with type 2 diabetes mellitus: a nationwide, population-based cohort studyE Lin, Hans Garmo, Mieke Van Hemelrijck, et al.
European Journal of Cancer (Oxford, England : 1990)|January 23, 2013
Risk of suicide in men with low-risk prostate cancerSigrid Carlsson, Fredrik Sandin, Katja Fall, et al.
Breast Cancer Research and Treatment|April 19, 2014
Birth size in the most recent pregnancy and maternal mortality in premenopausal breast cancer by tumor characteristicsMohammadhossein Hajiebrahimi, Sven Cnattingius, Mats Lambe, et al.
BJU International|January 22, 2015
Causes of death in men with localized prostate cancer: a nationwide, population-based studyMieke Van Hemelrijck, Yasin Folkvaljon, Jan Adolfsson, et al.
Pageof 17